Mutual Pharmaceutical Co. v. Bartlett
Holding
State-law design-defect claims that turn on the adequacy of a drug"s warnings are pre-empted by federal law under PLIVA v. Mensing.
Judgment
Reversed, 5-4, in an opinion by Samuel Alito on Jun 24, 2013. Justice Breyer filed a dissenting opinion in which Justice Kagan joined. Justice Sotomayor filed a dissenting opinion in which Justice Ginsburg joined.
Holding: State-law design-defect claims that turn on the adequacy of a drug”s warnings are pre-empted by federal law under”PLIVA v. Mensing.
Judgment:”Reversed, 5-4, in an opinion by Justice Alito on June 24, 2013. Justice Breyer filed a dissenting opinion in which Justice Kagan joined. Justice Sotomayor filed a dissenting opinion in which Justice Ginsburg joined.
Recommended Citation: Mutual Pharmaceutical Co. v. Bartlett, SCOTUSblog, https://www.scotusblog.com/cases/mutual-pharmaceutical-co-v-bartlett/